Anebulo Pharmaceuticals Inc (ANEB)
1.84
-0.04
(-2.13%)
USD |
NASDAQ |
Nov 01, 16:00
Anebulo Pharmaceuticals Market Cap: 47.72M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 47.72M |
| October 31, 2024 | 48.75M |
| October 30, 2024 | 47.98M |
| October 29, 2024 | 49.14M |
| October 28, 2024 | 47.46M |
| October 25, 2024 | 47.46M |
| October 24, 2024 | 49.27M |
| October 23, 2024 | 49.01M |
| October 22, 2024 | 47.73M |
| October 21, 2024 | 48.24M |
| October 18, 2024 | 50.87M |
| October 17, 2024 | 47.46M |
| October 16, 2024 | 49.01M |
| October 15, 2024 | 49.27M |
| October 14, 2024 | 47.46M |
| October 11, 2024 | 48.75M |
| October 10, 2024 | 48.50M |
| October 09, 2024 | 50.57M |
| October 08, 2024 | 49.01M |
| October 07, 2024 | 49.67M |
| October 04, 2024 | 50.57M |
| October 03, 2024 | 49.53M |
| October 02, 2024 | 51.35M |
| October 01, 2024 | 51.47M |
| September 30, 2024 | 50.05M |
| Date | Value |
|---|---|
| September 27, 2024 | 53.16M |
| September 26, 2024 | 50.83M |
| September 25, 2024 | 47.98M |
| September 24, 2024 | 54.20M |
| September 23, 2024 | 57.57M |
| September 20, 2024 | 79.87M |
| September 19, 2024 | 53.94M |
| September 18, 2024 | 51.87M |
| September 17, 2024 | 58.87M |
| September 16, 2024 | 54.20M |
| September 13, 2024 | 53.94M |
| September 12, 2024 | 54.20M |
| September 11, 2024 | 45.90M |
| September 10, 2024 | 50.05M |
| September 09, 2024 | 49.53M |
| September 06, 2024 | 46.68M |
| September 05, 2024 | 46.68M |
| September 04, 2024 | 48.75M |
| September 03, 2024 | 46.94M |
| August 30, 2024 | 49.79M |
| August 29, 2024 | 47.36M |
| August 28, 2024 | 47.36M |
| August 27, 2024 | 52.64M |
| August 26, 2024 | 50.44M |
| August 23, 2024 | 54.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
43.83M
Minimum
Oct 16 2023
208.23M
Maximum
May 21 2021
93.41M
Average
73.39M
Median
Apr 02 2024
Market Cap Benchmarks
| Revance Therapeutics Inc | 604.25M |
| NovaBay Pharmaceuticals Inc | 3.664M |
| Palatin Technologies Inc | 23.46M |
| iBio Inc | 23.06M |
| Theriva Biologics Inc | 2.000M |
Market Cap Related Metrics
| Price to Book Value | 12.52 |
| Price | 1.84 |
| Earnings Yield | -17.39% |